Published in Int J Vasc Med on March 15, 2012
Potential serum biomarkers in the pathophysiological processes of stroke. Expert Rev Neurother (2014) 0.81
Serum tissue inhibitor of matrix metalloproteinase-1 levels are associated with mortality in patients with malignant middle cerebral artery infarction. BMC Neurol (2015) 0.77
Treadmill exercise promotes neuroprotection against cerebral ischemia-reperfusion injury via downregulation of pro-inflammatory mediators. Neuropsychiatr Dis Treat (2016) 0.75
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics (1988) 70.41
Multiple biomarkers for the prediction of first major cardiovascular events and death. N Engl J Med (2006) 15.60
Randomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST) Lancet (1998) 10.64
Pathology of the vulnerable plaque. J Am Coll Cardiol (2006) 7.79
Dual role of matrix metalloproteinases (matrixins) in intimal thickening and atherosclerotic plaque rupture. Physiol Rev (2005) 3.30
Histological assessment of 526 symptomatic carotid plaques in relation to the nature and timing of ischemic symptoms: the Oxford plaque study. Circulation (2006) 2.53
Neovascularization in human atherosclerosis. Circulation (2006) 2.44
Carotid endarterectomy--an evidence-based review: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology (2005) 2.26
Critical cap thickness and rupture in symptomatic carotid plaques: the oxford plaque study. Stroke (2008) 1.80
Cytokines regulate vascular functions related to stability of the atherosclerotic plaque. J Cardiovasc Pharmacol (1995) 1.77
Matrix metalloproteinases in development and disease. Birth Defects Res C Embryo Today (2006) 1.61
Reanalysis of the final results of the European Carotid Surgery Trial. Stroke (2003) 1.47
Circulating markers of inflammation and atherosclerosis. Atherosclerosis (2003) 1.41
Association of multiple inflammatory markers with carotid intimal medial thickness and stenosis (from the Framingham Heart Study). Am J Cardiol (2007) 1.26
Inflammatory cytokines and cardiovascular disease. Curr Drug Targets Inflamm Allergy (2003) 1.10
Intraplaque MMP-8 levels are increased in asymptomatic patients with carotid plaque progression on ultrasound. Atherosclerosis (2005) 1.09
Cardiovascular biomarkers: added value with an integrated approach? Circulation (2007) 0.97
Serum values of metalloproteinase-2 and metalloproteinase-9 as related to unstable plaque and inflammatory cells in patients with greater than 70% carotid artery stenosis. J Vasc Surg (2004) 0.94
Linking inflammation and atherogenesis: Soluble markers identified for the detection of risk factors and for early risk assessment. Clin Chim Acta (2005) 0.90
Multiple biological predictors for vulnerable carotid lesions. Cerebrovasc Dis (2009) 0.89
Evaluating the carotid plaque: going beyond stenosis. Cerebrovasc Dis (2009) 0.89
Human carotid plaque calcification and vulnerability. Relationship between degree of plaque calcification, fibrous cap inflammatory gene expression and symptomatology. Cerebrovasc Dis (2009) 0.86
Biomarkers for atherosclerosis: pathophysiological role and pharmacological modulation. Curr Opin Lipidol (2006) 0.85
Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression. Eur J Vasc Endovasc Surg (2004) 0.82
Evaluation of serum matrix metalloproteinases as biomarkers for detection of neurological symptoms in carotid artery disease. Vasc Endovascular Surg (2009) 0.82
Elevation in plasma MMP-9 following carotid endarterectomy is associated with particulate cerebral embolisation. Eur J Vasc Endovasc Surg (2004) 0.80
The relationship between plasma MMP-1, -7, -8 and -13 levels and embolic potential during carotid endoluminal intervention. Eur J Vasc Endovasc Surg (2004) 0.77
Multiple biological predictors for vulnerable carotid lesions. Cerebrovasc Dis (2009) 0.89
MRI plaque imaging detects carotid plaques with a high risk for future cerebrovascular events in asymptomatic patients. PLoS One (2013) 0.82